HYPERCOAGULABILITY IN CANCER
- 1 April 1996
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 10 (2) , 499-530
- https://doi.org/10.1016/s0889-8588(05)70349-x
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Clinical trials with anticoagulant and antiplatelet therapiesCancer and Metastasis Reviews, 1992
- Tissue factor as a tumor procoagulantCancer and Metastasis Reviews, 1992
- HLA-DR is a procoagulantBiochemical and Biophysical Research Communications, 1991
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- Serial Impedance Plethysmography for Suspected Deep Venous Thrombosis in OutpatientsNew England Journal of Medicine, 1986
- The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemiaThe Journal of Pediatrics, 1982
- A syndrome of thrombosis and hemorrhage complicating l-asparaginase therapy for childhood acute lymphoblastic leukemiaThe Journal of Pediatrics, 1982
- The George E. Brown Memorial LectureCirculation, 1952